{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:55:46Z","timestamp":1781657746292,"version":"3.54.5"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Previous studies have revealed an increased risk of second primary malignancies (SPMs) after colorectal cancer (CRC); however, no previous investigation has quantified differences in the risk of SPMs based on the histological subtypes of first primary CRC.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Patients diagnosed with first primary CRC between 2000 and 2011 were identified from the Surveillance, Epidemiology, and End Results cancer registries. The patients were divided into three cohorts: classical adenocarcinoma (CA), mucinous adenocarcinoma (MA), and signet-ring cell carcinoma (SRCC). Standardized incidence ratios were calculated to assess the risk of SPMs among the patients.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Overall risk of SPMs was significantly higher among patients with three histological subtypes of CRC than in the general population. The risk of esophagus cancer was significantly increased in SRCC. The risk of small intestine, colon and rectum, and corpus uteri cancers was high in three histological subtypes, with the highest risk observed in SRCC, followed by MA. Increased risks of second stomach, uterus, urinary bladder, kidney, and thyroid cancers were only observed in CA patients, while increased risk of second renal pelvis cancer was limited to MA patients. Furthermore, the high overall risk of SPMs in CA patients persisted regardless of clinicopathological factors. After surgery combined with chemotherapy treatment, CA patients were more prone to developing second small intestine, colon and rectum cancers than those treated with surgery only. A lower second prostate cancer risk was observed in rectal CA patients treated with surgery combined with radiotherapy than in patients treated with surgery only.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The present study revealed that the risk of developing SPMs after CRC varied based on the histological subtypes of the first primary CRC. Although the mechanisms underlying the observed patterns of SPM risk remain unknown, the study provided insights into future cancer surveillance based on the histological subtypes of CRC.<\/jats:p>","DOI":"10.3389\/fonc.2021.650937","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T06:34:55Z","timestamp":1615358095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer"],"prefix":"10.3389","volume":"11","author":[{"given":"Meijuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongbo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjie","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3322\/caac.21565","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/cncr.28076","article-title":"Anatomic subsite of primary colorectal cancer and subsequent risk and distribution of second cancers","volume":"119","author":"Phipps","year":"2013","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/cam4.1437","article-title":"Excessive risk of second primary cancers in young-onset colorectal cancer survivors","volume":"7","author":"He","year":"2018","journal-title":"Cancer Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e644","DOI":"10.1634\/theoncologist.2019-0266","article-title":"Second primary malignancies in patients with colorectal cancer: a population-based analysis","volume":"25","author":"Jia","year":"2020","journal-title":"Oncologist"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/cncr.22013","article-title":"Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975\u20132001","volume":"107","author":"Ahmed","year":"2006","journal-title":"Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2147\/OTT.S129220","article-title":"Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study","volume":"10","author":"Yang","year":"2017","journal-title":"Onco Targets Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/SLA.0b013e3182a69f7e","article-title":"Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis","volume":"258","author":"Nitsche","year":"2013","journal-title":"Ann Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/j.clcc.2017.06.010","article-title":"Clinical analysis of primary colorectal signet-ring cell carcinoma","volume":"17","author":"Liang","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/annonc\/mdt591","article-title":"Metastatic pattern in colorectal cancer is strongly influenced by histological subtype","volume":"25","author":"Hugen","year":"2014","journal-title":"Ann Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1245\/s10434-012-2321-7","article-title":"Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base","volume":"19","author":"Hyngstrom","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12876-019-1083-0","article-title":"Prognoses of different pathological subtypes of colorectal cancer at different stages: a population-based retrospective cohort study","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3322\/caac.21286","article-title":"American cancer society colorectal cancer survivorship care guidelines","volume":"65","author":"El-Shami","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"B14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrclinonc.2013.41","article-title":"Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors","volume":"10","author":"Travis","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nrc1749","article-title":"Mechanisms of therapy-related carcinogenesis","volume":"5","author":"Allan","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"B16","first-page":"793","article-title":"Second primary cancers after sporadic and familial colorectal cancer","volume":"10","author":"Hemminki","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B17","first-page":"432","article-title":"Molecular pathology of colorectal carcinoma. A systematic review centred on the new role of the pathologist","volume":"104","author":"Remo","year":"2012","journal-title":"Pathologica"},{"key":"B18","doi-asserted-by":"publisher","first-page":"686879","DOI":"10.1155\/2014\/686879","article-title":"Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis","volume":"2014","author":"Pancione","year":"2014","journal-title":"J Immunol Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"71036","DOI":"10.3390\/cancers11071036","article-title":"Morphology and molecular features of rare colorectal carcinoma histotypes","volume":"11","author":"Remo","year":"2019","journal-title":"Cancers"},{"key":"B20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/jnci\/djy137","article-title":"Smoking and risk of colorectal cancer sub-classified by tumor-infiltrating T cells","volume":"111","author":"Hamada","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"B21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/aje\/kwaa005","article-title":"Smoking-related risks of colorectal cancer by anatomical subsite and sex","volume":"189","author":"Gram","year":"2020","journal-title":"Am J Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1200\/JCO.2014.56.8444","article-title":"Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies","volume":"32","author":"Gibson","year":"2014","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/jnci\/djj442","article-title":"Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer","volume":"98","author":"Dignam","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1053\/j.gastro.2009.07.039","article-title":"Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome","volume":"137","author":"Stoffel","year":"2009","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/jnci\/djs351","article-title":"Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome","volume":"104","author":"Win","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"B27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","article-title":"Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database","volume":"66","author":"Moller","year":"2017","journal-title":"Gut"},{"key":"B28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1200\/JCO.2014.58.1322","article-title":"Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines","volume":"33","author":"Stoffel","year":"2015","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10689-015-9862-4","article-title":"Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis","volume":"15","author":"Casellas-Cabrera","year":"2016","journal-title":"Fam Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/jjco\/hyv137","article-title":"Young patients with colorectal cancer have increased risk of second primary cancers","volume":"45","author":"Liang","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1055\/s-0031-1283870","article-title":"Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma","volume":"138","author":"Benedix","year":"2013","journal-title":"Zentralbl Chir"},{"key":"B32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ijc.28981","article-title":"Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor","volume":"136","author":"Hugen","year":"2015","journal-title":"Int J Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/sj.bjc.6604955","article-title":"Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and\/or irinotecan-based chemotherapy","volume":"100","author":"Catalano","year":"2009","journal-title":"Br J Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/annonc\/mdi244","article-title":"Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer","volume":"16","author":"Negri","year":"2005","journal-title":"Ann Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ejca.2011.12.004","article-title":"Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer","volume":"48","author":"Mekenkamp","year":"2012","journal-title":"Eur J Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e658","DOI":"10.1097\/MD.0000000000000658","article-title":"Prognostic comparison between mucinous and non-mucinous adenocarcinoma in colorectal cancer","volume":"94","author":"Park","year":"2015","journal-title":"Medicine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.7326\/0003-4819-156-11-201206050-00002","article-title":"Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study","volume":"156","author":"Henderson","year":"2012","journal-title":"Ann Intern Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6126","DOI":"10.1200\/JCO.2005.02.543","article-title":"Occurrence of second cancers in patients treated with radiotherapy for rectal cancer","volume":"23","author":"Birgisson","year":"2005","journal-title":"J Clin Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1200\/JCO.2014.58.6693","article-title":"No increased risk of second cancer after radiotherapy in patients treated for rectal or endometrial cancer in the randomized TME, PORTEC-1, and PORTEC-2 trials","volume":"33","author":"Wiltink","year":"2015","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/bjs.10327","article-title":"Risk of second primary cancer in patients treated with radiotherapy for rectal cancer","volume":"104","author":"Martling","year":"2017","journal-title":"Br J Surg"},{"key":"B41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/annonc\/mdw661","article-title":"Incidence of second tumors after treatment with or without radiation for rectal cancer","volume":"28","author":"Rombouts","year":"2017","journal-title":"Ann Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1111\/j.1743-6109.2011.02455.x","article-title":"Testicular function after radiotherapy for rectal cancer\u2013a review","volume":"8","author":"Buchli","year":"2011","journal-title":"J Sex Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.650937\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T06:34:59Z","timestamp":1615358099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.650937\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":42,"alternative-id":["10.3389\/fonc.2021.650937"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.650937","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"article-number":"650937"}}